“In connection with numerous inquiries, the Administration of BIOLEC JSC informs that on 31.12.2020 to the Ministry of Health of Ukraine we have indeed sent an Application for state registration of a medicinal product – vaccine Gam-KOVID-Vak, a combined vector vaccine for the prevention of coronavirus infection caused by SARS-CoV-2 virus, produced by FDBU “NDCEM named after M.F. Gamaleya, the Ministry of Health of the Russian Federation,” the report says.
It is too early to talk about the reasons for the company’s decision and their consequences, although if officials from the Ministry of Health are to be believed, the drug has no chance of being registered and, moreover, no one will buy it with funds from the state budget.
All the hype around the scandalous vaccine looks more like preparation of an infofield for the next political multi-purpose schemes. It is worth noting that Biolik is owned by Russian Viktor Kharitonin, who also owns the Russian pharmaceutical company Farmstandard, which produces the Sputnik V vaccine. Biolek was previously owned by the family of former Ukrainian Health Minister Raisa Bogatyryova. The company was established more than a hundred years ago and indeed has vast experience in vaccine production.
As for the drug from the Russian Federation itself, the Sputnik V vaccine never completed the clinical trials of the third phase, but it was nevertheless released on the market, inoculating budgetary employees and military personnel with it, in fact, testing the drug on people in the Russian Federation;
“Spztnik V is also actively trying to export the vaccine, but so far there are not many willing buyers. Hungary, which earlier announced its readiness to buy the vaccine, has abandoned the idea. Neighboring Belarus and distant Venezuela have ordered the vaccine.
The Sputnik V vaccine is reportedly scheduled to complete Phase III clinical trials in December 2021.
Read also: Ukraine will receive a Chinese vaccine for COVID-19 in March 2021.
Shutterstock/FOTODOM UKRAINE photos were used
